DK0388799T3 - Anvendelse af human beta-interferon til stimulering af erythropoiesis - Google Patents

Anvendelse af human beta-interferon til stimulering af erythropoiesis

Info

Publication number
DK0388799T3
DK0388799T3 DK90104936.1T DK90104936T DK0388799T3 DK 0388799 T3 DK0388799 T3 DK 0388799T3 DK 90104936 T DK90104936 T DK 90104936T DK 0388799 T3 DK0388799 T3 DK 0388799T3
Authority
DK
Denmark
Prior art keywords
human beta
beta interferon
stimulate erythropoiesis
erythropoiesis
stimulate
Prior art date
Application number
DK90104936.1T
Other languages
Danish (da)
English (en)
Inventor
Rita Machalevicz
Original Assignee
Interpharm Lab Ltd
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Lab Ltd, Univ Ramot filed Critical Interpharm Lab Ltd
Application granted granted Critical
Publication of DK0388799T3 publication Critical patent/DK0388799T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK90104936.1T 1989-03-19 1990-03-15 Anvendelse af human beta-interferon til stimulering af erythropoiesis DK0388799T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL89662A IL89662A (en) 1989-03-19 1989-03-19 Pharmaceutical compositions comprising interferon-beta

Publications (1)

Publication Number Publication Date
DK0388799T3 true DK0388799T3 (da) 1998-03-30

Family

ID=11059803

Family Applications (2)

Application Number Title Priority Date Filing Date
DK94112221T DK0643973T3 (da) 1989-03-19 1990-03-15 Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
DK90104936.1T DK0388799T3 (da) 1989-03-19 1990-03-15 Anvendelse af human beta-interferon til stimulering af erythropoiesis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK94112221T DK0643973T3 (da) 1989-03-19 1990-03-15 Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi

Country Status (12)

Country Link
US (1) US5104653A (fr)
EP (2) EP0643973B1 (fr)
JP (1) JP2883669B2 (fr)
AT (2) ATE240116T1 (fr)
AU (1) AU619960B2 (fr)
CA (1) CA2011992C (fr)
DE (2) DE69031355T2 (fr)
DK (2) DK0643973T3 (fr)
ES (2) ES2198409T3 (fr)
GR (1) GR3024763T3 (fr)
IL (1) IL89662A (fr)
ZA (1) ZA901994B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
DE69636790T2 (de) * 1995-07-25 2007-10-11 Toray Industries, Inc. Interferon-beta gegen knochenerkrankungen
JP2002509077A (ja) * 1998-02-09 2002-03-26 ユニヴァースティ オブ サザーン カリフォルニア 赤血球形成促進方法
DE60139339D1 (de) * 2000-11-07 2009-09-03 Novartis Vaccines & Diagnostic Stabilisierte interferonzusammensetzungen
EP1334177B1 (fr) * 2000-11-14 2005-01-26 Université Libre de Bruxelles Production et utilisation de cellules dendritiques
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
CA2561141A1 (fr) * 2004-03-31 2005-11-17 Nitromed, Inc. Methodes de traitement des troubles sanguins a l'aide de composes donneurs d'oxyde nitrique
US20080293724A1 (en) * 2006-02-17 2008-11-27 Nitromed, Inc. Methods Using Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
CA1294215C (fr) * 1986-10-27 1992-01-14 Ze'ev Shaked Compositions pharmaceutiques d'interferon beta recombinant et methodes de formulation
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders

Also Published As

Publication number Publication date
IL89662A0 (en) 1989-09-28
EP0643973A1 (fr) 1995-03-22
CA2011992A1 (fr) 1990-09-19
DE69031355D1 (de) 1997-10-09
ATE240116T1 (de) 2003-05-15
DE69034076T2 (de) 2003-11-20
IL89662A (en) 1997-11-20
ES2198409T3 (es) 2004-02-01
GR3024763T3 (en) 1997-12-31
US5104653A (en) 1992-04-14
DE69031355T2 (de) 1998-01-08
EP0388799A3 (fr) 1991-07-31
AU5144590A (en) 1990-09-20
JPH0314523A (ja) 1991-01-23
JP2883669B2 (ja) 1999-04-19
EP0388799A2 (fr) 1990-09-26
DK0643973T3 (da) 2003-09-08
ZA901994B (en) 1990-12-28
DE69034076D1 (de) 2003-06-18
ATE157544T1 (de) 1997-09-15
ES2107414T3 (es) 1997-12-01
EP0388799B1 (fr) 1997-09-03
CA2011992C (fr) 2003-04-29
EP0643973B1 (fr) 2003-05-14
AU619960B2 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
DE69034194D1 (de) N-Acylderivate der Antitumor-Antibiotika vom Typ LL-E33288
DK0388799T3 (da) Anvendelse af human beta-interferon til stimulering af erythropoiesis
DK0426521T3 (da) Anvendelse af interleukin 2 til behandling af leukæmi
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK350286D0 (da) Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum, dets fremstilling og anvendelse
DK328088A (da) Farmaceutisk komposition til behandling af tumorer
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
IE871358L (en) Interferon for carcinoma
IT1223485B (it) Procedimento per la preparazione di componenti ceramici
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
FI863079A0 (fi) Kontinuerligt frigoerande fenyletanolaminderivatkompositioner.
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
DK606583A (da) Farmaceutiske formuleringer med cytostatisk virkning
IE872843L (en) Recombinant beta-interferon compositions
ES274950Y (es) Cuadro de componentes ceramicos
ES280295Y (es) Mesa perfeccionada de billar